argenx SE

Common Name
argenx
Country
Netherlands
Sector
Healthcare
Industry
Biotechnology
Employees
1,599
Ticker
ARGX
Exchange
EURONEXT
Description
argenx SE is a commercial-stage biopharmaceutical company focused on developing and delivering innovative antibody-based therapies for severe autoimmune diseases. Operating as a global and fully-integ...

Disclosures of argenx

Explore argenx's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from argenx's official channels and fully traceable to its official company sources.

The table below lists all of argenx's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.

NameReporting Period
Annual Report2024
Annual Report2023
Annual Report2023
ESG Report2023
20-F2022
Annual Report2022
ESG Report2022
20-F2021
Annual Report2021
ESG Report2021
20-F2020
Annual Report2020
Annual Report2019
Annual Report2019
Annual Report2018
Annual Report2018
Annual Report2017
Annual Report2017
Annual Report2016
Annual Report2015
Annual Report2014
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?